TipRanks on MSN
Eli Lilly Stock Gets New Street-High Price Target – Citi Says Oral Weight-Loss Drug Sales Potential Is Underestimated
Eli Lilly (NYSE:LLY) shares have been hitting new highs, boosted by a recent strong earnings report and another raised ...
Morgan Stanley analyst Terence Flynn raised the firm’s price target on Eli Lilly (LLY) to $1,171 from $1,090 and keeps an Overweight rating on the ...
Eli Lilly, Novo Nordisk, Hims & Hers Health Shares Move Lower After Trump Calls Out 'Fat-Loss Drugs'
Shares of Eli Lilly And Co (NYSE:LLY) and Novo Nordisk A/S (NYSE:NVO) are moving lower in Thursday’s after-hours session after President Donald Trump indicated that weight-loss drugs are going to come ...
Eli Lilly (NYSE: LLY) has outperformed the market over the past 10 years by 15.62% on an annualized basis producing an average annual return of 28.38%. Currently, Eli Lilly has a market capitalization ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback